Your experience on this site will be improved by allowing cookies.

Dig Deeper With Our Customized Reports

Pi Pharma Intelligence takes the necessary steps and analysis to provide service reports to identify market access barriers, analyse regulatory and patent trends in the therapy areas and overview all clinical programs around a particular molecule.

FTO Report Infringement Risk Report

FTO Report

What Awaits You!

  • Patent Landscape Review : Conducts detailed searches on patents, patent applications, utility models relevant to your product or technology.

  • Comprehensive Opinion : Delivers an expert analysis on whether your product, process, or technology may infringe on third-party patents within the targeted marketing region.

  • Informed Decision-Making : Provides actionable insights to navigate the patent landscape and minimize risks before product development or market entry.

Request Report

Infringement Risk Report

The Benefits You’ll Unlock

  • Risk Identification : Pinpoints any direct or indirect patent infringements that may arise during the development, registration, or commercialization of your products in target markets.

  • Strategic Guidance : Outlines potential consequences of infringements and helps you understand the risks associated with market activities.

  • Mitigating Legal Risks : Supports proactive decision-making to safeguard your business from costly patent disputes.

Request Report

Our Reports That Tell The Whole Story

Explore Our Work in Action

  • Assessment evaluating a generic entry into the market.
  • Evaluation of the patent situation
  • Identifying possible generic market access options
  • Provide generic suppliers, including evaluation of potential generic FDF/ APIs suppliers.
Request Report

Success Story

”I was impressed at the detailed data that PI pharma is offering for academic and industrial driven research. The reports are very informative and the platform is user-friendly. My research team could optimize our research quality”

Dr. Nimer Alkhatib
PhD Health economics and outcomes

”Here we are about to complete our second year of cooperation with our strategic partner “PI”. In fact, they do not stop developing and improving, and I am very excited to try the new version which I expect will be no less perfect than the current version”

Dr.Soad Essam
Intellectual Property head

Pi Report Featured Question

What’s the best market access strategy for my product?

We guide you in selecting the optimal sourcing countries and market models to ensure the fastest commercialization.

Where can I find a reliable finished dosage form (FDF) supplier?

Our platform technology helps identify FDF suppliers, along with their development stages.

How can I find qualified API suppliers?

We utilize our platform and report to pinpoint EU and US DMF-approved API suppliers.

Which therapy area is most vulnerable to patent cliffs?

Our database predicts when a molecule’s basic patent will expire, helping you stay ahead.

How can I get clinical updates on specific molecules?

Our clinical reports provide in-depth analysis of molecules’ clinical programs, categorizing them based on features like head-to-head comparisons and primary drugs.

How do I assess the risk in my portfolio?

Our dataset evaluates pricing risks and the threat from upcoming generics, helping you better manage your portfolio.